L1CAM and neoplasm: Robust preclinical safety testing in nonhuman primates expressing the identical CE7 L1CAM epitope in a similar normal tissue distribution to humans did not reveal any evidence for on-target, off-tumor toxicities at doses 100 times those given to humans (Kunkele et al. 2017).